IndustryHealthcareVenture CapitalInvestment IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series B Round By Violet Tang - December 10, 2018 — 18:06 Total: 0 Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China. Continue reading with a China Money Network subscription Join Now Already have an account or paid subscription? Log in
